ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Moffitt Cancer Center at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Moffitt Cancer Center takes part in 8 sessions at ESMO 2026 in Madrid. Its work spans treatment and outcomes across melanoma, breast, prostate, colorectal and lung cancers. It examines nivolumab with HBI-8000 or placebo in advanced melanoma.
| Organization | ESMO 2026 Attendance |
|---|---|
Moffitt Cancer Center Tampa, FL | |
US National Cancer Institute-designated comprehensive cancer centre in Tampa, Florida, combining patient care and research. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Abstract Fri Oct 23 16:25–16:35 Chair Sat Oct 24 10:15–11:45 Challenging clinical scenarios in melanoma and skin cancers Melanoma & skin cancers Talk Sat Oct 24 10:55–11:15 Adolescents and Young Adults (including oncofertility) Melanoma & skin cancers Poster Sat Oct 24 12:00–12:45 Host inherited genetic variation and the risk of hepatitis following immune checkpoint immunotherapy (ICI) of melanoma Melanoma & skin cancersBiomarkers & precision oncology Abstract Sun Oct 25 10:25–10:35 691O - A first in human phase 1 study of intrathecal peptide-pulsed dendritic cells for HER2+ and triple negative breast cancer leptomeningeal disease Sarcoma, CNS, head & neck and rare cancers Abstract Mon Oct 26 10:55–11:00 Poster Mon Oct 26 12:00–12:45 |
Find decision makers at Moffitt Cancer Center
Tell us what you sell and we’ll find the people at Moffitt Cancer Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction